Left atrial fibrosis predicts left ventricular ejection fraction response after atrial fibrillation ablation in heart failure patients: The Fibrosis-HF Study

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Bettina Kirstein - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Sebastian Neudeck - , Klinik für Innere Medizin und Kardiologie (am Herzzentrum), Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Thomas Gaspar - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Judith Piorkowski - , Technische Universität Dresden (Autor:in)
  • Simon Wechselberger - , Klinik für Innere Medizin und Kardiologie (am Herzzentrum), Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Mads Brix Kronborg - , Universität Aarhus (Autor:in)
  • Angela Zedda - , Klinik für Innere Medizin und Kardiologie (am Herzzentrum) (Autor:in)
  • Anastasia Hankel - , Steinbeis-Forschungszentrum Rhythm and Heart (Autor:in)
  • Ali El-Armouche - , Institut für Pharmakologie und Toxikologie, Technische Universität Dresden (Autor:in)
  • Jakub Tomala - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Thomas Schmidt - , Klinik für Innere Medizin und Kardiologie (am Herzzentrum) (Autor:in)
  • Julia Mayer - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Michael Wagner - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Stefan Ulbrich - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Liying Pu - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Utz Richter - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Yan Huo - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)
  • Christopher Piorkowski - , Herzzentrum Dresden GmbH – Universitätsklinik (Autor:in)

Abstract

Aims Atrial fibrillation (AF) and heart failure (HF) often coexist. Catheter ablation has been reported to restore left ventricular (LV) function but patients benefit differently. This study investigated the correlation between left atrial (LA) fibrosis extent and LV ejection fraction (LVEF) recovery after AF ablation. Methods and In this study, 103 patients [64 years, 69% men, 79% persistent AF, LVEF 33% interquartile range (IQR) (25–38)] unresults dergoing first time AF ablation were investigated. Identification of LA fibrosis and selection of ablation strategy were based on sinus rhythm voltage mapping. Continuous rhythm monitoring was used to assess ablation success. Improvement in post-ablation LVEF was measured as primary study endpoint. An absolute increase in post-ablation LVEF >_10% was defined as ‘Super Response’. Left atrial fibrosis was present in 38% of patients. After ablation LVEF increased by absolute 15% (IQR 6–25) (P < 0.001). Left ventricular ejection fraction improvement was higher in patients without LA fibrosis [15% (IQR 10–25) vs. 10% (IQR 0–20), P < 0.001]. An inverse correlation between LVEF improvement and the extent of LA fibrosis was found (R2 = 0.931). In multivariate analysis, the presence of LA fibrosis was the only independent predictor for failing LVEF improvement [odds ratio 7.2 (95% confidence interval 2.2–23.4), P < 0.001]. Echocardiographic ‘Super Response’ was observed in 55/64 (86%) patients without and 21/39 (54%) patients with LA fibrosis, respectively (P < 0.001). Conclusion Presence and extent of LA fibrosis predict LVEF response in HF patients undergoing AF ablation. The assessment of LA fibrosis may impact prognostic stratification and clinical management in HF patients with AF.

Details

OriginalspracheEnglisch
Seiten (von - bis)1812-1821
Seitenumfang10
FachzeitschriftEuropace
Jahrgang22
Ausgabenummer12
PublikationsstatusVeröffentlicht - 1 Dez. 2020
Peer-Review-StatusJa

Externe IDs

PubMed 32830233
ORCID /0000-0003-2514-9429/work/151437833
ORCID /0000-0002-1475-2559/work/161406710

Schlagworte

Schlagwörter

  • Ablation, Atrial fibrillation, Heart failure, Left atrial fibrosis, Left ventricular ejection fraction